When it comes to bioactive peptides, eledoisin acetate (CAS: 69-25-0) may not be a household name, yet it holds an irreplaceable position in neuropharmacological research. This white, powdery substance is essentially a synthetic analog of the natural tachykinin isolated from the salivary glands of Mediterranean octopuses. Endowed with exceptional receptor selectivity, it has become a critical tool for researchers exploring neuronal signaling pathways.
As a member of the tachykinin family, the core value of eledoisin acetate lies in its precise binding affinity for neurokinin receptors. Studies have demonstrated that it exhibits high affinity for both human neurokinin-1 (NK1) and neurokinin-3 (NK3) receptors. Notably, its EC₅₀ value for NK3 receptor binding can be as low as 0.22 nM, enabling efficient induction of receptor-mediated calcium influx responses. This unique characteristic grants it an unparalleled advantage in receptor functional characterization and signal transduction mechanism studies, providing a reliable model for elucidating the physiological roles of the tachykinin family.
The diversity of its biological activities has long been validated by the academic community. Early research revealed that it exerts a significant regulatory effect on ion transport, with a specific stimulatory action on frog skin ion channels that distinguishes its function from other tachykinins. Simultaneously, it displays complex physiological effects: low doses promote gastric acid secretion, while high doses yield an inhibitory effect. Additionally, it possesses vasodilatory and smooth muscle contractile activities, offering a multidimensional perspective for research in fields such as cardiovascular physiology and gastrointestinal function regulation.
In the realm of drug development, the value of eledoisin acetate is equally prominent. Tachykinin receptors are closely associated with various pathophysiological processes, including pain transmission and mood regulation. The well-defined pharmacological properties of eledoisin acetate make it an ideal positive control for the screening of receptor-targeted drugs. Its excellent chemical stability and reproducible biological effects further enhance experimental reliability, helping researchers shorten the drug development cycle.
From its discovery in octopus saliva to its status as a commonly used tool peptide in laboratories, the research journey of eledoisin acetate underscores the profound significance of natural bioactive substances in life science exploration. With the advancement of neuropharmacological research, this relatively niche peptide may provide new insights for the development of novel therapeutics for pain management and neurological disorders.
